ClinicalTrials.govpublic full text
Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC
non squamous cell lung cancer, non small cell lung cancer, docetaxel, sorafenib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830554
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.